BillionToOne Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 389

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 41

BillionToOne General Information

Description

Developer of a molecular counter platform intended to increase the resolution of cell-free DNA testing. The company's pan-cancer tumor-naive oncology test precisely quantifies tumor burden from a blood sample to track response to therapy and its prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize the signal-to-noise ratio and detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 1035 O'Brien Drive
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

BillionToOne Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BillionToOne Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-May-2024 00000 Completed Generating Revenue
7. Later Stage VC 15-Dec-2022 000.00 00000 000 Completed Generating Revenue
6. Later Stage VC (Series C) 16-Mar-2022 00000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series B) 14-Jun-2021 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series A) 22-Feb-2021 0000 000.00 0000 Completed Generating Revenue
3. Grant 01-Jan-2018 00000 00.00 Completed Generating Revenue
2. Seed Round 30-Sep-2017 $2.5M $2.5M Completed Generating Revenue
1. Accelerator/Incubator 22-Aug-2017 Completed Startup
To view BillionToOne’s complete valuation and funding history, request access »

BillionToOne Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series B-2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B-1 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A-6 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-5 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-4 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 000,000 00.000000 00 00 00 00 0.000
Series A-2 1,137,210 $0.000010 $0.8 $0.8 1x $0.8 3.05%
Series A-1 1,349,650 $0.000010 $0.4 $0.4 1x $0.4 3.62%
To view BillionToOne’s complete cap table history, request access »

BillionToOne Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular counter platform intended to increase the resolution of cell-free DNA testing. The company's pa
Decision/Risk Analysis
Menlo Park, CA
389 As of 2024
00000
0000000000 0 00000

000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000
Austin, TX
0000 As of 0000
00000
00000000 00000

000000

n ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
00000 0000000000 000
San Diego, CA
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BillionToOne Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Natera Formerly VC-backed Austin, TX 0000 00000 00000000 00000
Cradle Genomics Venture Capital-Backed San Diego, CA 00 000.00 000000000 000.00
Foundation Medicine Formerly VC-backed Cambridge, MA 0000 00000 00000000000
Myriad Genetics Corporation Salt Lake City, UT 0000 00000 00000000 00000
Invitae Formerly VC-backed San Francisco, CA 0000 00000 000000&0
You’re viewing 5 of 7 competitors. Get the full list »

BillionToOne Patents

BillionToOne Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230295741-A1 Molecule counting of methylated cell-free dna for treatment monitoring Pending 21-Mar-2022 0000000000 0
US-20220340971-A1 Fragment analysis for quantitative diagnostics of biological targets Pending 23-Mar-2021 0000000000
CA-3212749-A1 Fragment analysis for quantitative diagnostics of biological targets Pending 23-Mar-2021 0000000000
EP-4314336-A1 Fragment analysis for quantitative diagnostics of biological targets Pending 23-Mar-2021 0000000000
CA-3123684-A1 Non-invasive prenatal testing at early stage of pregnancy Pending 07-Jul-2020 G16B20/20
To view BillionToOne’s complete patent history, request access »

BillionToOne Executive Team (8)

Name Title Board Seat Contact Info
Oguzhan Atay Ph.D Co-Founder, Chief Executive Officer & Chairman
David Tsao Ph.D Co-Founder, Chief Technology Officer & Board Member
Thomas Lynch JD General Counsel & Chief Compliance Officer
Shan Riku Chief Product Officer
Ross Taylor Chief Financial Officer
You’re viewing 5 of 8 executive team members. Get the full list »

BillionToOne Board Members (7)

Name Representing Role Since
Casper de Clercq Norwest Venture Partners Board Observer 000 0000
David Tsao Ph.D BillionToOne Co-Founder, Chief Technology Officer & Board Member 000 0000
Firat Ileri Hummingbird Ventures Board Member 000 0000
Oguzhan Atay Ph.D BillionToOne Co-Founder, Chief Executive Officer & Chairman 000 0000
Swaroop Kolluri Neotribe Ventures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

BillionToOne Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BillionToOne Investors (41)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NYX Ventures Partners Venture Capital Minority 000 0000 000000 0
Brightway Future Capital Venture Capital Minority 000 0000 000000 0
Eczacıbaşı Momentum Corporate Venture Capital Minority 000 0000 000000 0
Lombardstreet Ventures Venture Capital Minority 000 0000 000000 0
Metaplanet Holdings Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 41 investors. Get the full list »

BillionToOne FAQs

  • When was BillionToOne founded?

    BillionToOne was founded in 2016.

  • Who is the founder of BillionToOne?

    Oguzhan Atay Ph.D, David Tsao Ph.D, and Sukrit Silas Ph.D are the founders of BillionToOne.

  • Who is the CEO of BillionToOne?

    Oguzhan Atay Ph.D is the CEO of BillionToOne.

  • Where is BillionToOne headquartered?

    BillionToOne is headquartered in Menlo Park, CA.

  • What is the size of BillionToOne?

    BillionToOne has 389 total employees.

  • What industry is BillionToOne in?

    BillionToOne’s primary industry is Decision/Risk Analysis.

  • Is BillionToOne a private or public company?

    BillionToOne is a Private company.

  • What is BillionToOne’s current revenue?

    The current revenue for BillionToOne is 000000.

  • How much funding has BillionToOne raised over time?

    BillionToOne has raised $281M.

  • Who are BillionToOne’s investors?

    NYX Ventures Partners, Brightway Future Capital, Eczacıbaşı Momentum, Lombardstreet Ventures, and Metaplanet Holdings are 5 of 41 investors who have invested in BillionToOne.

  • Who are BillionToOne’s competitors?

    Natera, Cradle Genomics, Foundation Medicine, Myriad Genetics, and Invitae are some of the 7 competitors of BillionToOne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »